Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
作者信息
Sevincok L, Uslu A, Kaynak H, Dereboy F
出版信息
J Psychiatry Neurosci. 2000 Mar;25(2):185.
Abstract
摘要
相似文献
1
Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.在一例无共病精神病理学的氟伏沙明难治性强迫症患者中加用舒必利。
J Psychiatry Neurosci. 2000 Mar;25(2):185.
2
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.低剂量利培酮增强氟伏沙明治疗强迫症：一项双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74. doi: 10.1016/j.euroneuro.2004.04.004.
3
What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?强迫症药物治疗的最佳方法是什么？
J Psychiatry Neurosci. 1998 Mar;23(2):136.
4
When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):111-3. doi: 10.1176/jnp.10.1.111a.
5
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.强迫症、5-羟色胺转运体基因启动子区域多态性与治疗反应
Pharmacogenomics J. 2002;2(3):176-81. doi: 10.1038/sj.tpj.6500090.
6
Fluvoxamine treatment of body dysmorphic disorder.氟伏沙明治疗躯体变形障碍。
J Clin Psychopharmacol. 1994 Feb;14(1):75-7.
7
High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.高剂量帕罗西汀治疗一名患有阿斯伯格障碍合并强迫症的青少年。
Psychiatry Clin Neurosci. 2009 Apr;63(2):251. doi: 10.1111/j.1440-1819.2009.01924.x.
8
Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.强迫型人格障碍在抗强迫药物治疗中的预测价值。
Eur Neuropsychopharmacol. 1997 Feb;7(1):45-9. doi: 10.1016/s0924-977x(96)00382-3.
9
Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.帕罗西汀用于一名患有强迫症、神经性厌食症和分裂型人格障碍的患者。
J Psychiatry Neurosci. 1998 May;23(3):179-80.
10
An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
Clin Neuropharmacol. 2000 May-Jun;23(3):157-60. doi: 10.1097/00002826-200005000-00005.
本文引用的文献
1
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.在对选择性5-羟色胺再摄取抑制剂难治的强迫症中加用奥氮平：一项开放标签病例系列研究
J Clin Psychiatry. 1999 Aug;60(8):524-7. doi: 10.4088/jcp.v60n0804.
2
Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.利培酮增强5-羟色胺再摄取抑制剂治疗强迫症及相关障碍的疗效
J Clin Psychiatry. 1997 Mar;58(3):119-22. doi: 10.4088/jcp.v58n0306.
3
Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.氟伏沙明难治性强迫症中加用氟哌啶醇。一项针对有抽动和无抽动患者的双盲、安慰剂对照研究。
Arch Gen Psychiatry. 1994 Apr;51(4):302-8. doi: 10.1001/archpsyc.1994.03950040046006.
4
Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.舒必利和氯丙嗪对精神分裂症患者自闭症及阳性精神病性症状的影响——与药物浓度的关系
Psychopharmacology (Berl). 1985;85(1):8-13. doi: 10.1007/BF00427315.
5
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?超越血清素假说：多巴胺在某些形式的强迫症中所起的作用？
J Clin Psychiatry. 1990 Aug;51 Suppl:36-43; discussion 55-8.
6
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.氟伏沙明治疗强迫症的对照试验：对血清素能理论的启示
Am J Psychiatry. 1990 Sep;147(9):1209-15. doi: 10.1176/ajp.147.9.1209.
7
Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.氟伏沙明难治性强迫症中添加抗精神病药物治疗
Am J Psychiatry. 1990 May;147(5):652-4. doi: 10.1176/ajp.147.5.652.
Zotero 插件